Workflow
康臣药业11月18日斥资441.66万港元回购30万股

Core Viewpoint - 康臣药业 announced a share buyback plan, intending to repurchase 300,000 shares at a cost of HKD 4.4166 million on November 18, 2025 [1] Company Summary - 康臣药业 plans to spend HKD 4.4166 million for the repurchase of 300,000 shares [1]